Article By:
StockNews
Sunday, July 4, 2021 1:59 PM EDT
With rising demand for elective surgeries that had been on hold during the worst of the COVID-19 pandemic, two established medical equipment companies, Asensus (ASXC) and Surgalign (SRGA), should benefit in the coming months.